NEUROWEB

NEUROWEB project improves healthcare delivery achieving knowledge-based, personalised diagnosis and therapy through vertical integration of existing clinical and genetic databases.NEUROWEB stimulates the sharing of knowledge on cerebrovascular diseases using an on-line web platform.

The amount of biomedical information that can be accessed through the Internet has reached a level no one could have dreamt of just ten years ago. The success of the genome sequencing projects has created an enormous amount of data that cannot be manually analysed. Since disease phenotypes arise from complex interaction between genetic factors and environment, the value of high-throughput genomic research would be dramatically enhanced by associations with key patient data. These data are generally available but of disparate quality and sources.The development of a data management system which integrates genomic databanks, clinical databases, and data mining tools embedded into a common resource accessible to health care professionals would be extremely advantageous.

Ischemic stroke is a major health problem in the developed countries. It is a complex, multigenic disorder, since there are several subtypes and risk factors, and most of the cases have non-mendelian inheritance. The integration and the analysis of a large number of well-defined clinical, radiological and molecular data will improve the evidence on the different roles played by genetic and environmental risk factors in stroke pathophysiology.

Within the framework of cerebrovascular disease, the objectives of the NEUROWEB project are:

  • To integrate clinical and genetic databases of the participating centres, different for structure and language, into a single virtual database;
  • To query the genetic databanks containing human genetic profiles present on the web;
  • To generate new knowledge on single patients with cerebrovascular disease, in order to achieve personalised prevention, diagnosis and therapy;
  • To promote collaborative research practices among the research communities involved in the project in order to share and enhance knowledge in the neurological domain.

The final aim of the NEUROWEB project is to foster vertical integration between clinical and genetic data in other common and complex diseases (i.e. cardiovascular diseases and tumours), in order to improve and personalise healthcare delivery in EC.

For further information, please visit:
http://www.neurowebkc.eu

Project co-ordinator:
Istituto Nazionale Neurologico "Carlo Besta" (IT)

Partners:

  • Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche (IT);
  • University of Milan – BICOCCA (IT)
  • Regione Lombardia (IT);
  • Erasmus University of Rotterdam (NL);
  • Medical School of Patras University (GR);
  • Orszagos Pszichiatriai es Neurologiai Intezet (HU);
  • University of Veszprém (HU);
  • SirseNet spa (IT);
  • Microsystems srl (IT);
  • Velti A.E. (GR)

Timetable: from 06/06 – to 05/08

Total cost: € 2.751.129

EC funding: € 1.883.500

Instrument: STREP

Project Identifier: IST-2006-518513

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

AI-Powered CRISPR could Lead to Faster G…

Stanford Medicine researchers have developed an artificial intelligence (AI) tool to help scientists better plan gene-editing experiments. The technology, CRISPR-GPT, acts as a gene-editing “copilot” supported by AI to help...

Groundbreaking AI Aims to Speed Lifesavi…

To solve a problem, we have to see it clearly. Whether it’s an infection by a novel virus or memory-stealing plaques forming in the brains of Alzheimer’s patients, visualizing disease processes...

AI Spots Hidden Signs of Depression in S…

Depression is one of the most common mental health challenges, but its early signs are often overlooked. It is often linked to reduced facial expressivity. However, whether mild depression or...

AI Tools Help Predict Severe Asthma Risk…

Mayo Clinic researchers have developed artificial intelligence (AI) tools that help identify which children with asthma face the highest risk of serious asthma exacerbation and acute respiratory infections. The study...

ChatGPT 4o Therapeutic Chatbot 'Ama…

One of the first randomized controlled trials assessing the effectiveness of a large language model (LLM) chatbot 'Amanda' for relationship support shows that a single session of chatbot therapy...

AI Model Forecasts Disease Risk Decades …

Imagine a future where your medical history could help predict what health conditions you might face in the next two decades. Researchers have developed a generative AI model that uses...

AI Model Indicates Four out of Ten Breas…

A project at Lund University in Sweden has trained an AI model to identify breast cancer patients who could be spared from axillary surgery. The model analyses previously unutilised information...

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...